Anti-myeloma efficacy of BCMA CAR-iNKT is enhanced with a long-acting IL-7, rhIL7hyFc

Bibliographic Details
Published in:	Journal of Bone Oncology
Main Authors:	Julie O'Neal, Matthew L. Cooper, Julie K. Ritchey, Susan Gladney, Jessica Niswonger, L. Sofía González, Emily Street, Gabriel J. Haas, Alun Carter, Parmeshwar N. Amayta, Feng Gao, Byung Ha Lee, Donghoon Choi, Melissa Berrien-Elliott, Alice Zhou, Todd A. Fehniger, Mike P. Rettig, John F. DiPersio
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2212137424000174

Similar Items

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors
by: Dan li, et al.
Published: (2024-07-01)

Traversing the bench to bedside journey for iNKT cell therapies
by: Julie O’Neal, et al.
Published: (2024-08-01)

Correction: rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors
Published: (2025-03-01)

rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors
by: Miyoung Kim, et al.
Published: (2024-03-01)

Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of rhIL-7-hyFc, a Hybrid Fc-Fused Long-Acting Interleukin-7, to Support Optimal Dosing Regimens in Patients with Solid Cancer
by: Park S, et al.
Published: (2025-10-01)

Dose Optimization of rhIL‐7‐hyFc for Patients With Lymphopenia Using a Neonatal Fc Receptor‐Mediated Recycling‐Based and Target‐Mediated Drug Disposition Pharmacokinetic Model
by: Hye Seon Jeon, et al.
Published: (2025-05-01)

IL-21-armored B7H3 CAR-iNKT cells exert potent antitumor effects
by: Yilin Liu, et al.
Published: (2024-01-01)

The iNKT cell ligand α-GalCer prevents murine septic shock by inducing IL10-producing iNKT and B cells
by: Yun Hoo Park, et al.
Published: (2024-09-01)

Potential role of IL-17-producing iNKT cells in type 1 diabetes.
by: Shamin Li, et al.
Published: (2014-01-01)

Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy
by: Mariko Takami, et al.
Published: (2024-08-01)

Generation of Mouse iNKT Cell Lines
by: Xiangming Li, et al.
Published: (2013-03-01)

Generation of Human iNKT Cell Lines
by: Xiangming Li, et al.
Published: (2013-03-01)

The Role of Autophagy in iNKT Cell Development
by: Guan Yang, et al.
Published: (2018-11-01)

Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
by: Stephen Ahn, et al.
Published: (2023-03-01)

MAIT and iNKT cells in tissue homeostasis and repair
by: Rafael Almeida Paiva, et al.
Published: (2025-05-01)

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease.
by: Joshua J Field, et al.
Published: (2017-01-01)

CAR-iNKT cells: redefining the frontiers of cellular immunotherapy
by: Magdalena Niedzielska, et al.
Published: (2025-07-01)

The Ras/MAPK pathway is required for generation of iNKT cells.
by: Taishan Hu, et al.
Published: (2011-05-01)

Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients
by: Diana Ferraro, et al.
Published: (2021-11-01)

Human iNKT Cells Modulate Macrophage Survival and Phenotype
by: J. Pedro Loureiro, et al.
Published: (2022-07-01)

New insights into iNKT cells and their roles in liver diseases
by: Xinyu Gu, et al.
Published: (2022-10-01)

CD8+ T-cell immunity orchestrated by iNKT cells
by: Yingyu Qin, et al.
Published: (2023-01-01)

Transcriptional re-programming of liver-resident iNKT cells into T-regulatory type-1-like liver iNKT cells involves extensive gene de-methylation
by: Javier Montaño, et al.
Published: (2024-09-01)

Innate iNKT cells: from biological insight to clinical impact
by: Antonia Rotolo, et al.
Published: (2025-09-01)

Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment
by: Agnieszka Lawrenczyk, et al.
Published: (2014-07-01)

Global trends and frontiers in iNKT cells: a bibliometric and visualized analysis
by: Dan Zhang, et al.
Published: (2025-07-01)

Role of CD1d and iNKT cells in regulating intestinal inflammation
by: Sung Won Lee, et al.
Published: (2024-01-01)

Primary Mouse Invariant Natural Killer T (iNKT) Cell Purification and Transduction
by: Gloria Delfanti, et al.
Published: (2023-07-01)

22511 Glycolipid-loaded nanoparticles harness iNKT cells for tumor immunotherapy
by: Travis Shute, et al.
Published: (2021-03-01)

Over-activation of iNKT cells aggravate lung injury in bronchopulmonary dysplasia mice
by: Ming-Yan Wang, et al.
Published: (2024-11-01)

Lipid accumulation in adipose tissue-resident iNKT cells contributes to an inflammatory phenotype
by: Imogen Morris, et al.
Published: (2024-12-01)

TET proteins regulate Drosha expression and impact microRNAs in iNKT cells
by: Marianthi Gioulbasani, et al.
Published: (2024-09-01)

Correction: Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
by: Rebeca Jimeno, et al.
Published: (2020-03-01)

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
by: Sarah Cooley, et al.
Published: (2019-07-01)

Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes
by: Alex Look, et al.
Published: (2023-04-01)

Recent advances in iNKT cell development [version 1; peer review: 3 approved]
by: Kristin Hogquist, et al.
Published: (2020-02-01)

Efficient Production of Functional Human NKT Cells from Induced Pluripotent Stem Cells − Reprogramming of Human Vα24+iNKT Cells
by: Daisuke Yamada, et al.
Published: (2017-05-01)

Peripheral blood iNKT cells display an activated profile with both increased apoptosis and dysfunction in obesity
by: Chloé Wilkin, et al.
Published: (2025-09-01)

Single-cell transcriptomic profiling reveals diversity in human iNKT cells across hematologic tissues
by: Reyka G. Jayasinghe, et al.
Published: (2025-05-01)

Editorial: Cognate recognition, functional properties and immunotherapeutic applications of iNKT cells: leveling the road to the clinic
by: A. Raul Castaño, et al.
Published: (2025-01-01)